1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cale Jacobs, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions anakinra (150mg), Saline intraarticularly - Anterior Cruciate Ligament Tear | Phase 2 | Terminated | Cale Jacobs, PhD | 6 | 2019-06-20 | 2021-11-24 |
| Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions Gel-One, Saline Placebo - Anterior Cruciate Ligament | Early Phase 1 | Completed | Cale Jacobs, PhD | 24 | 2017-04-06 | 2022-09-13 |
Anterior Cruciate Ligament Injuries (1)
Hyaluronic Acid (1) · Interleukin 1 Receptor Antagonist Protein (1) · Sodium Chloride (1)
United States (2)
Austin Stone, MD (1)